Table 1: Demographics.

N

12

% Female

92%

Age (mean, years)

61.6 +/-12.2

Race

White n (%)

10 (83%)

Hispanic/Latino n (%)

0

Asian n (%)

2 (17%)

Black/African American n (%)

0

BMI (kg/m2)

21.6 +/-3.3

Tobacco use history

Never smoker n (%)

10 (83%)

Former smoker n (%)

2 (17%)

Average pack years (years)

15

Co-morbidities

Asthma n (%)

3 (25%)

COPD n (%)

0

Immunocompromised n (%)

1 (8.3%)

Rheumatologic disease n (%)

1 (8.3%)

GERD n (%)

7 (58%)

Diabetes n (%)

0

HTN n (%)

3 (25%)

Pre-operative PFTs

FEV1/FVC% predicted

74%

FEV1 L (% predicted)

2.22 L (83.4 %)

FVC L (% predicted)

2.98 L (90.1%)

DLCO % predicted

81%

Indication for surgery

Failure of medical therapy n (%)

3 (25%)

Cavitary disease n (%)

7 (58%)

Hemoptysis n (%)

2 (16%)

NTM species

MAI n (%)

12 (100%)

M abscessus n (%)

0

M xenopi n (%)

0

NTM-LD: Non-tuberculous mycobacterial lung disease; BMI: Body mass index; COPD: Chronic obstructive pulmonary disease; GERD: Gastroesophageal reflux disease; HTN: Hypertension; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity; DLCO: Diffusing capacity of the lungs for carbon monoxide; NTM: Non-tuberculous mycobacteria; MAI: Mycobacterium avium intracellulare; M abscessus: Mycobacterium abscessus; M xenopi: Mycobacterium xenopi